BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

383 related articles for article (PubMed ID: 31889816)

  • 1. Oncolytic Newcastle disease virus reduces growth of cervical cancer cell by inducing apoptosis.
    Keshavarz M; Nejad ASM; Esghaei M; Bokharaei-Salim F; Dianat-Moghadam H; Keyvani H; Ghaemi A
    Saudi J Biol Sci; 2020 Jan; 27(1):47-52. PubMed ID: 31889816
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oncolytic effects of Hitchner B1 strain of newcastle disease virus against cervical cancer cell proliferation is mediated by the increased expression of cytochrome C, autophagy and apoptotic pathways.
    Mozaffari Nejad AS; Fotouhi F; Mehrbod P; Keshavarz M; Alikhani MY; Ghaemi A
    Microb Pathog; 2020 Oct; 147():104438. PubMed ID: 32777353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oncolytic Newcastle disease virus carrying the IL24 gene exerts antitumor effects by inhibiting tumor growth and vascular sprouting.
    Wu Q; Jin Y; Li S; Guo X; Sun W; Liu J; Li Q; Niu D; Zou Y; Du X; Li Y; Zhao T; Li Z; Li X; Ren G
    Int Immunopharmacol; 2024 Jul; 136():112305. PubMed ID: 38823178
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant oncolytic Newcastle disease virus displays antitumor activities in anaplastic thyroid cancer cells.
    Jiang K; Song C; Kong L; Hu L; Lin G; Ye T; Yao G; Wang Y; Chen H; Cheng W; Barr MP; Liu Q; Zhang G; Ding C; Meng S
    BMC Cancer; 2018 Jul; 18(1):746. PubMed ID: 30021550
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Non-replicating Newcastle Disease Virus as an adjuvant for DNA vaccine enhances antitumor efficacy through the induction of TRAIL and granzyme B expression.
    Mohebbi A; Ebrahimzadeh MS; Baghban Rahimi S; Saeidi M; Tabarraei A; Mohebbi SR; Shirian S; Gorji A; Ghaemi A
    Virus Res; 2019 Feb; 261():72-80. PubMed ID: 30599161
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
    Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
    Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synergy between hemagglutinin 2 (HA2) subunit of influenza fusogenic membrane glycoprotein and oncolytic Newcastle disease virus suppressed tumor growth and further enhanced by Immune checkpoint PD-1 blockade.
    Miri SM; Ebrahimzadeh MS; Abdolalipour E; Yazdi M; Hosseini Ravandi H; Ghaemi A
    Cancer Cell Int; 2020; 20():380. PubMed ID: 32782438
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of Apoptosis Induction by Newcastle Disease Virus LaSota Strain in Human Breast Carcinoma Cells.
    Kalantari A; Farashi Bonab S; Keyvanfar H; Mortazavi P
    Arch Razi Inst; 2020 Oct; 75(3):367-376. PubMed ID: 33025777
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Newcastle disease virus LaSota strain induces apoptosis and activates the TNFα/NF-κB pathway in canine mammary carcinoma cells.
    Wang J; Li M; Li M
    Vet Comp Oncol; 2023 Sep; 21(3):520-532. PubMed ID: 37282822
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oncolytic effect of Newcastle disease virus is attributed to interferon regulation in canine mammary cancer cell lines.
    Santos MR; Xavier PLP; Pires PRL; Rochetti AL; Rosim DF; Scagion GP; de Campos Zuccari DAP; Munir M; Ferreira HL; Fukumasu H
    Vet Comp Oncol; 2021 Sep; 19(3):593-601. PubMed ID: 33871162
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antitumor effect of oncolytic respiratory syncytial virus via the tumor necrosis factor-alpha induction and ROS-bax-mediated mechanisms.
    Samadi M; Mokhtari-Azad T; Nejati A; Norooz-Babaei Z; Foroushani AR; Haghshenas MR; Adjaminejad F; Zargaran H; Salimi V; Ghaemi A
    BMC Cancer; 2023 Aug; 23(1):803. PubMed ID: 37641004
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Newcastle disease virus strain AF2240 as an oncolytic virus: A review.
    Kalyanasundram J; Hamid A; Yusoff K; Chia SL
    Acta Trop; 2018 Jul; 183():126-133. PubMed ID: 29626432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic Modification of Oncolytic Newcastle Disease Virus for Cancer Therapy.
    Cheng X; Wang W; Xu Q; Harper J; Carroll D; Galinski MS; Suzich J; Jin H
    J Virol; 2016 Jun; 90(11):5343-5352. PubMed ID: 27009956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of three properties of Newcastle disease virus for fighting cancer: tumor-selective replication, antitumor cytotoxicity, and immunostimulation.
    Fournier P; Bian H; Szeberényi J; Schirrmacher V
    Methods Mol Biol; 2012; 797():177-204. PubMed ID: 21948477
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined therapy of oncolytic Newcastle disease virus and rhizomes extract of Rheum ribes enhances cancer virotherapy in vitro and in vivo.
    Al-Shammari AM; Jalill RDA; Hussein MF
    Mol Biol Rep; 2020 Mar; 47(3):1691-1702. PubMed ID: 31970625
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Newcastle disease virus exerts oncolysis by both intrinsic and extrinsic caspase-dependent pathways of cell death.
    Elankumaran S; Rockemann D; Samal SK
    J Virol; 2006 Aug; 80(15):7522-34. PubMed ID: 16840332
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intratumoral Virotherapy with Wild-Type Newcastle Disease Virus in Carcinoma Krebs-2 Cancer Model.
    Yurchenko KS; Glushchenko AV; Gulyaeva MA; Bi Y; Chen J; Shi W; Adamenko LS; Shestopalov AM
    Viruses; 2021 Mar; 13(4):. PubMed ID: 33806229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. STAT3 Contributes To Oncolytic Newcastle Disease Virus-Induced Immunogenic Cell Death in Melanoma Cells.
    Shao X; Wang X; Guo X; Jiang K; Ye T; Chen J; Fang J; Gu L; Wang S; Zhang G; Meng S; Xu Q
    Front Oncol; 2019; 9():436. PubMed ID: 31192135
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesenchymal stem cells enhance the oncolytic effect of Newcastle disease virus in glioma cells and glioma stem cells via the secretion of TRAIL.
    Kazimirsky G; Jiang W; Slavin S; Ziv-Av A; Brodie C
    Stem Cell Res Ther; 2016 Oct; 7(1):149. PubMed ID: 27724977
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development of Molecular Mechanisms and Their Application on Oncolytic Newcastle Disease Virus in Cancer Therapy.
    Huang F; Dai C; Zhang Y; Zhao Y; Wang Y; Ru G
    Front Mol Biosci; 2022; 9():889403. PubMed ID: 35860357
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.